Evaluation of molecular targeted cancer drug by changes in tumor marker doubling times.

Enooku K, Tateishi R, Kanai F, Kondo Y, Masuzaki R, Goto T, Shiina S, Yoshida H, Omata M, Koike K
J Gastroenterol. 2012 47 (1): 71-8

PMID: 21935635 · DOI:10.1007/s00535-011-0462-2

MeSH Terms (23)

Aged alpha-Fetoproteins Antineoplastic Agents Biomarkers Biomarkers, Tumor Carcinoma, Hepatocellular Disease Progression Female Humans Indoles Liver Neoplasms Male Middle Aged Molecular Targeted Therapy Oxindoles Propionates Protein Kinase Inhibitors Protein Precursors Prothrombin Pyrroles Time Factors Treatment Outcome Tumor Burden

Connections (1)

This publication is referenced by other Labnodes entities:

Links